Skip to content
Biotron Limited
  • Home
  • About Us
    • Board of Directors
    • Management Team
  • Technology
    • Clinical programs
    • Non-clinical programs
    • Intellectual property
  • News/Resources
    • Newsletters
    • In the news
    • Scientific Presentations
    • Scientific Publications
  • Investor Centre
    • ASX Announcements
    • Financial Reports
      • Annual
      • Half-year
      • Quarterly
    • Corporate Directory
    • Shareholder services
    • Rights Issue
    • Top 40 Shareholders
    • Top 40 Option Holders
    • Corporate Governance
    • Corporate Presentations
  • Contacts

ASX Announcements 2023

  • 14 Dec 2023

    Shareholder Update

  • 22 Nov 2023

    Results of Annual General Meeting

  • 22 Nov 2023

    Presentation at Annual General Meeting

  • 27 Oct 2023

    Report on Activities for the Quarter Ended 30 September 2023

  • 27 Oct 2023

    Quarterly Report 30 September 2023

  • 26 Oct 2023

    Application for Quotation of Securities

  • 24 Oct 2023

    Presentation to Investors

  • 20 Oct 2023

    Annual Report and Notice of AGM

  • 26 Sep 2023

    Shareholder Update

  • 11 Sep 2023

    Response to ASX Price Query

  • 25 Aug 2023

    Corporate Governance Statement 2023

  • 25 Aug 2023

    Appendix 4G

  • 25 Aug 2023

    Year End Accounts and Preliminary Final Report

  • 16 Aug 2023

    Completion of Phase 2 COVID Clinical Trial

  • 28 Jul 2023

    Report on Activities for the Quarter Ended 30 June 2023

  • 28 Jul 2023

    Quarterly Report 30 June 2023

  • 12 May 2023

    Second Site Approved for Phase 2 COVID-19 Trial

  • 4 May 2023

    Commencement of Phase 2 COVID-19 Clinical Trial

  • 27 Apr 2023

    Report on Activities for the Quarter Ended 31 March 2023

  • 27 Apr 2023

    Quarterly Report 31 March 2023

  • 9 Mar 2023

    Completion of Phase 2 HIV-1 Clinical Trials

  • 21 Feb 2023

    Presentation of BIT225 COVID-19 Data at International Conference

  • 17 Feb 2023

    Half-year Report 31 December 2022

  • 7 Feb 2023

    Notice of Cessation of Securities

  • 31 Jan 2023

    Report on Activities for the Quarter Ended 31 December 2022

  • 31 Jan 2023

    Quarterly Report 31 December 2022

 

 

 

  • <<
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • >>

Investor Centre

  • Investor Centre
    • ASX Announcements
    • Annual reports
    • Corporate Directory
    • Shareholder services
    • Top 40 Shareholders
    • Top 40 Option Holders
    • Corporate Governance
    • Corporate Presentations
© Biotron Limited 2016       ABN 60 086 399 144        Site updated 24 April 2025        Legal Notices and Privacy
Cleantalk Pixel